Verapamil treatment for women with bipolar disorder
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background Additional pharmacological treatments are needed for patients with bipolar disorder. We describe our experience with verapamil in an inclusive, sequential series of outpatient women (some pregnant) with bipolar disorder.Methods All women who were prescribed verapamil for bipolar disorder (n = 37) were included. We used the criterion of 50% reduction in scores on the Mania Rating Scale or the Hamilton Rating Scale for Depression to define response for women who were treated for an acute episode of bipolar hypomania/mania or depression, respectively. For euthymic women who chose verapamil maintenance treatment, we evaluated whether they met criteria for a recurrent episode during therapy.Results Treatment for acute episodes was initiated in 28 women. Of women with depression and mania, 39% and 100% responded, respectively. Seven of the nine patients (77%) with mixed states responded: all seven improved to response criterion on the mania scale, and two responded on the depression scales as well. Six of eight patients who received continuation therapy remained well.Conclusions These data provide evidence that verapamil is effective for mania. The response rate for mania compares favorably to that for other mood stabilizers. After decades of case reports and underpowered clinical trials, we must definitively study verapamil for efficacy and gender specificity in bipolar disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While an initial small RCT did not show anti‐manic efficacy for verapamil,185 there is some evidence that it may work as an adjunctive therapy (level 4)186 or as monotherapy in women (level 4).187 Larger studies are needed before a conclusion can be made.”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“These subjects had 17-item Hamilton Rating Scale for Depression (HRSD) (Hamilton 1960) scores of 15 and/or a Mania Rating Scale (MRS) score of 12 (derived from the Schedule for Affective Disorders and Schizophrenia) (Endicott et al 1978).”
MethodA Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.179 · Cited by 488 · cited 1×
“Common clinical situations are: women who plan to conceive and require maintenance medication to prevent bipolar episodes; the emergence of mania or depression during pregnancy in women who have discontinued medication, since pregnancy offers no protective effect ( Viguera et al 2000 ); and women who have recurrent ep…”
BackgroundA Reevaluation of Risk of In Utero Exposure to Lithium
Cohen, L. S. (1994) · JAMA · doi:10.1001/jama.1994.03510260078033 · Cited by 475 · cited 1×
“Clinicians need alternative agents for use during pregnancy because valproate and carbamazepine are morphologic and neurobehavioral teratogens (Delgado-Escueta and Janz 1992). Although less teratogenic than implied by data from the Registry (Cohen et al 1994), lithium is associated with fetal growth enhancement (Jacob…”
BackgroundThe Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (1994) · Pediatrics · doi:10.1542/peds.93.1.137 · Cited by 426
Bech, Bolwig, Kramp, P., & Rafaelsen, O. J. (1979) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1979.tb04484.x · Cited by 405
A Self-Report Scale to Diagnose Major Depressive Disorder
Zimmerman, M. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800110062008 · Cited by 336
Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester
Jacobson, S. J., Ceolin, L., Kaur, P., Pastuszak, A., Einarson, T., Koren, G., Jones, K., Johnson, K., Sahn, D., Donnenfeld, A. E., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)90346-5 · Cited by 322
Research works printed but not linked: 1
- Delgado-Escueta, 1992, Consensus guidelines, Neurology, 42, 149
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Whole-genome association study of bipolar disorder
Sklar, P., Smoller, J. W., Fan, J., Ferreira, M. A. R., Perlis, R. H., Chambert, K., Nimgaonkar, V. L., McQueen, M. B., Faraone, S. V., Kirby, A., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002151 · Cited by 697
Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394
“The effects of calcium channel blockers, such as verapamil, in the treatment of bipolar disorder have been studied (74–76), although their efficacy remains unproven (77).”
BackgroundSelf-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1384850 · Cited by 187
“Seventy-seven percent of the woman (seven out of nine) with mixed states fulfilled response criteria on the mania scale, and two responded on the depression scales as well (Wisner et al. 2002).”
BackgroundTreatment-resistant bipolar disorder
Gitlin, M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001793 · Cited by 184
Metadata
- Authors
- Wisner, K. L., Peindl, K. S., Perel, J. M., Hanusa, B. H., Piontek, C. M., & Baab, S.
- Affiliations
- University of Louisville (US)
- University of Pittsburgh Medical Center (US)
- Case Western Reserve University (US)
- Corresponding author
- Wisner, Katherine L.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 51
- Issue
- 9
- Pages
- 745-752
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2065107928
- Cited by
- 41
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 3 · 2013: 1 · 2012: 2
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-57375, R01MH060335, MH-60335, MH30915)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- verapamil, bipolar disorder, women, mania, depression, mixed states, maintenance therapy, mood stabilizers, pregnancy, treatment response, gender differences
- MeSH terms
- Anti-Arrhythmia Agents, Bipolar Disorder, Female, Humans, Pregnancy, Psychiatric Status Rating Scales, Verapamil
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Verapamil treatment for women with bipolar disorder. https://app.cochat.ai/papers/10.1016/s0006-3223(01)01338-5
- The paper
- Wisner, K. L., Peindl, K. S., Perel, J. M., Hanusa, B. H., Piontek, C. M., & Baab, S. (2002). Verapamil treatment for women with bipolar disorder. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(01)01338-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.